Financial Performance - The company's operating revenue for Q1 2025 was ¥38,661,101.09, representing a 34.85% increase compared to ¥28,670,179.99 in the same period last year[4]. - The net profit attributable to shareholders was -¥5,301,909.06, a decrease of 215.97% from ¥4,571,726.52 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥7,393,596.85, down 320.24% from ¥3,357,116.13 year-on-year[4]. - Net profit for Q1 2025 was a loss of ¥6,121,932.54, compared to a profit of ¥3,276,392.33 in Q1 2024[20]. - The total comprehensive income for the period was -6,121,932.54 RMB, compared to 3,276,392.33 RMB in the previous period, marking a decline of approximately 287%[21]. Cash Flow - The cash flow from operating activities was -¥5,629,481.95, a decline of 123.86% compared to ¥23,596,244.96 in the same period last year[5]. - In Q1 2025, the company's operating cash flow was -5,629,481.95 RMB, a significant decrease from 23,596,244.96 RMB in Q1 2024, indicating a decline of approximately 124% year-over-year[23]. - Total cash inflow from operating activities in Q1 2025 was 37,817,602.02 RMB, down 40.5% from 63,642,173.32 RMB in Q1 2024[24]. - Cash and cash equivalents at the end of Q1 2025 were 176,081,617.44 RMB, down from 238,364,031.05 RMB at the end of Q1 2024, representing a decrease of approximately 26%[25]. - The company incurred cash outflows from investing activities of 45,505,702.46 RMB in Q1 2025, compared to 82,333,578.89 RMB in Q1 2024, reflecting a reduction of about 44.8%[25]. - Cash inflow from financing activities was 4,696,865.58 RMB in Q1 2025, contrasting with an outflow of -11,212,636.27 RMB in Q1 2024, indicating a turnaround in financing cash flow[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,795,748,384.28, a decrease of 1.44% from ¥1,822,019,588.53 at the end of the previous year[5]. - Total liabilities decreased to ¥151,110,382.89 from ¥171,259,654.60 year-over-year[17]. - The company's equity attributable to shareholders decreased slightly to ¥1,602,701,069.83 from ¥1,608,002,978.89 year-over-year[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,382[9]. - The total number of shares held by the top 10 shareholders includes 4,610,000 shares by Ningbo Tongtai Xin Venture Capital Partnership and 2,460,000 shares by Ningbo Tongyuan Youbo Venture Capital Partnership[10]. - The top shareholder, Hai Luo Chuang Tou Holdings (Zhuhai) Co., Ltd., holds 426,602 shares, with no shares held in ordinary securities accounts[11]. Regulatory and Compliance - The company received an administrative regulatory measure decision from the China Securities Regulatory Commission on January 17, 2025, which is being addressed with corrective measures[12]. - The company held a board meeting on April 25, 2025, to review and approve corrections related to prior accounting errors and periodic report adjustments[14]. - The company is focused on compliance and has implemented specific rectification measures in response to regulatory feedback[13]. Research and Development - Research and development expenses totaled ¥5,122,522.39, accounting for 13.25% of operating revenue, down from 20.48% in the previous year[5]. - Research and development expenses for Q1 2025 were ¥5,122,522.39, a decrease from ¥5,872,639.91 in Q1 2024[19]. Inventory and Receivables - The company experienced an increase in inventory unit costs and recognized inventory impairment provisions, impacting net profit negatively[8]. - The company attributed the decline in net profit to increased depreciation costs and a decrease in cash collection from major clients[8]. - Accounts receivable increased to ¥167,516,216.89 from ¥165,084,679.92, reflecting a slight growth of about 1.5%[15]. - The company’s other receivables amounted to ¥2,837,160.81, showing a slight increase from ¥2,562,833.11[15]. - The company’s prepayments rose significantly to ¥4,690,813.10 from ¥2,819,681.48, marking an increase of approximately 66%[15]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters[19]. - The company's financial report for the first quarter of 2025 is unaudited, indicating a need for further review before finalization[15].

关于 2025 年第一季度计提资产减值准备的公告 证券代码：688053 证券简称：思科瑞 公告编号：2025-023 成都思科瑞微电子股份有限公司 为真实反映公司的财务状况、资产价值及经营情况，根据《企业会计准则》以 及公司会计政策、会计估计的相关规定，本着谨慎性原则，公司对合并报表范围内 截至2025年3月31日的存货进行了减值测试。经测试，2025年第一季度计提资产减值 损失469.21万元，其中存货跌价损失469.21万元。 三、本次计提减值准备对公司的影响 一、2025 年一季度计提资产减值准备情况 根据《企业会计准则》和相关会计政策的相关规定，结合公司的实际情况，为 了真实、准确地反映公司 2025 年第一季度的财务状况和经营成果，基于谨慎性原 则，公司拟对截至 2025年3月31 日合并报表范围内可能发生信用及资产减值损失的 有关资产计提资产减值准备。 2025年第一季度，公司计提资产减值损失和信用减值损失共计896.28万元，具 体如下： 二、 计提减值准备事项的具体说明 （一）信用减值损失 为真实反映公司的财务状况、资产价值及经营情况，根据《企业会计准则》以 及公司会计政策、会计估计的相关规 ...

本次公司不分配不转赠。 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 名称 | 持有数量(万股) | 占总股本 | 增减情况 | | --- | --- | --- | --- | | | | 比例(%) | (万股) | | 宁波通泰信创业投资合伙企业(有限合伙) | 461.00 | 10.65 | -41.00 | | 宁波通元优博创业投资合伙企业(有限合伙) | 246.00 | 5.68 | 不变 | | 混沌天成期货股份有限公司 | 135.05 | 3.12 | 不变 | | 何红梅 | 119.00 | 2.75 | 不变 | | 苏刚 | 92.01 | 2.13 | 12.01 | | 宁波松瓴创业投资合伙企业(有限合伙) | 60.00 | 1.39 | 不变 | | 胡丽君 | 50.48 | 1.17 | 新进 | | 海螺创投控股(珠海)有限公司 | 42.66 | 0.99 | -27.03 | | 程聪 | 36.98 | 0.85 | 新进 | | 四川发展证券投资基金管理有限公司-四川资本市场纾困发展 证券投资基金合 ...

思科瑞公告，2025年第一季度营收为3866.11万元，同比增长34.85%；净亏损530.19万元，去年同期净 利润457.17万元。 ...

Financial Performance - The net profit attributable to ordinary shareholders for 2023 is RMB 43,097,713.78, with a distributable profit of RMB 106,778,476.52 as of December 31, 2023[7]. - The proposed cash dividend is RMB 3.10 per 10 shares, totaling RMB 30,711,800.13, which represents 71.26% of the net profit attributable to shareholders[8]. - The company's revenue for 2023 was CNY 200,838,880.34, a decrease of 13.75% compared to the previous year[26]. - Net profit attributable to shareholders for 2023 was CNY 47,840,488.21, down 47.68% from the previous year[26]. - Adjusted net profit for 2023 was CNY 42,481,749.53, reflecting a decline of 47.78% year-over-year[26]. - The net profit attributable to shareholders decreased by 47.69%, primarily due to a decline in operating revenue compared to the same period last year, alongside increased costs from expanded testing capabilities[32]. - The gross margin decreased from 67.85% in 2022 to 53.97% in 2023, indicating a significant decline in profitability[107]. - The operating costs increased by 23.46% year-on-year, amounting to CNY 92.44 million[119]. - The company reported a significant increase in net cash flow from operating activities, up 143.65% to CNY 69.83 million[119]. - The company's cash and cash equivalents rose by 84.04% to CNY 308.30 million, reflecting improved liquidity[149]. Audit and Compliance - The company has received a standard unqualified audit report from Zhonghui Certified Public Accountants[6]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[10]. - The company has not disclosed any special arrangements for corporate governance[9]. - The company has established a robust internal control system to enhance governance and ensure compliance with relevant laws and regulations[175]. - The board of directors consists of 7 members, including 3 independent directors, ensuring compliance with legal requirements[176]. Research and Development - Research and development expenses accounted for 11.10% of operating revenue, up from 9.16% in the previous year[30]. - R&D investment in 2023 was 22.30 million yuan, an increase of 4.53% year-on-year, resulting in the acquisition of 14 invention patents and 30 software copyrights[43]. - The total R&D investment for the year reached ¥22,296,614.18, representing a 4.53% increase from the previous year, with R&D expenses accounting for 11.10% of total revenue[91]. - The company has developed over 36,000 testing software programs, a 28.5% increase year-on-year, and over 23,000 testing adapters, a 25.1% increase year-on-year[99]. - The company has established a comprehensive R&D system focused on reliability testing technologies and processes, continuously improving its service capabilities[66]. Market and Industry Position - The detection service industry in China has over 54,000 institutions, generating a service output value exceeding 400 billion yuan, indicating significant market potential[74]. - The military electronic component reliability testing market is expected to grow in correlation with China's increasing military expenditure, which rose from 33.2% in 2010 to 40.00% in 2019[162]. - The company is positioned in a recovery cycle similar to the global detection industry in 2010, suggesting potential for performance improvement and value reassessment in 2023[77]. - The company has established reliability testing service bases in Chengdu, Wuxi, and Xi'an, strategically located in key military equipment production areas[78]. - The company benefits from a favorable market environment as the regulatory framework for the detection industry becomes more open and market-oriented, providing growth opportunities[81]. Operational Challenges - The company faced a decline in detection order volume due to delays in military orders, impacting overall operational performance[102]. - The company is experiencing a low capacity utilization rate due to a downturn in the military industry, which may continue to affect its financial performance[106]. - The company’s reliance on military electronic component reliability testing exposes it to risks from potential quality accidents that could damage its reputation[105]. - The company must continuously invest in technology development to keep pace with rapid advancements in electronic components, or risk falling behind in the market[104]. - The company faces challenges such as a rapid increase in the variety of electronic components and a shortage of high-end professional talent in the reliability testing industry[83]. Corporate Governance - The company has not reported any changes in the implementation of differential voting rights during the reporting period[186]. - The company has not established a red-chip structure for corporate governance[187]. - The total remuneration for the chairman is reported at 600,000 yuan for the year[188]. - The company has seen a stable leadership structure with independent directors serving terms until 2026, ensuring continuity in governance[191]. - The company has strengthened investor relations management through various communication channels, ensuring timely and accurate information disclosure[180]. Future Plans and Strategies - The company aims to establish a first-class reliability service platform and expand its operations in Chengdu, Wuxi, Xi'an, and Hainan, focusing on environmental testing and electromagnetic compatibility projects[166]. - The company plans to accelerate the construction of reliability testing centers in key regions, enhancing its production capacity and competitive strength in the market[167]. - The company will leverage advanced technology to develop an integrated reliability testing center in Wenchang, aiming for high efficiency and low-cost solutions for aerospace products[167]. - The company plans to expand its testing and experimental service capabilities by establishing multiple new testing bases and laboratories, particularly in the southwest, northwest, and eastern regions of China[170]. - Over the next three years, the company will deepen organizational structure reforms to enhance management efficiency and strengthen the construction of functional departments[171].

证券代码：688053 证券简称：思科瑞 公告编号：2025-021 成都思科瑞微电子股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024年年度股东大会 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 5 月 16 日 14 点 00 分 召开地点：成都市高新区安泰四路 68 号 19 楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 16 日 至2025 年 5 月 16 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 股东大会召开日期：2025年5月16日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 东大会召开当日的交易 ...

证券代码：688053 证券简称：思科瑞 公告编号：2025-016 成都思科瑞微电子股份有限公司 第二届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 根据《中华人民共和国公司法》及《公司章程》的有关规定，第二届监事会第九 次会议于 2025 年 4 月 15 日以专人送达方式发出会议通知，并于 2025 年 4 月 25 日 16 时以现场方式在公司会议室召开，会议应到监事 3 人，实到监事 3 人，由监事会 主席施明明先生召集并主持。会议符合《中华人民共和国公司法》及《公司章程》的 有关规定，会议召开合法、有效。会议通过如下决议： 本议案尚需提交公司 2024 年年度股东大会审议。 （二）审议通过《关于 2024 年度财务决算报告的议案》 监事会认为，公司《2024 年度财务决算报告》是基于对 2024 年度公司整体运营 情况的总结。同意《成都思科瑞微电子股份有限公司 2024 年度财务决算报告》。 表决结果：3 名监事同意，0 名监事反对，0 名监事弃权。 本议案尚需提 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 根据《中华人民共和国公司法》及本公司《公司章程》的有关规定，第二届 董事会第十三次会议于 2025 年 4 月 15 日以专人送达等方式发出会议通知，并 于 2025 年 4 月 25 日 15 时于公司会议室以现场方式召开，会议应到董事 7 人， 实到董事 7 人，会议由董事长张亚先生召集并主持，公司监事、高级管理人员列 席本次会议，符合《中华人民共和国公司法》及《公司章程》的有关规定，会议 召开合法、有效。会议通过如下决议： 二、董事会会议审议情况 经与会董事审议，做出以下决议： 证券代码：688053 证券简称：思科瑞 公告编号：2025-015 成都思科瑞微电子股份有限公司 第二届董事会第十三次会议决议公告 （一）审议通过《关于 2024 年度总经理工作报告的议案》 董事会认为，公司总经理依据《公司法》《证券法》等国家有关法律、法规 和《公司章程》的规定，认真履行董事会的各项职责，严格执行董事会的各项决 议，认真推进董事会各项决议的有效实施，促 ...

证券代码：688053 证券简称：思科瑞 公告编号：2025-018 成都思科瑞微电子股份有限公司 关于 2024 年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 鉴于成都思科瑞微电子股份有限公司（以下简称"公司"）2024 年度 归属于上市公司股东的净利润为负，未实现盈利，公司管理层综合考虑公司的持 续稳定经营、长远发展和全体股东利益，2024 年度公司拟不派发现金红利，不 送红股，不以公积金转增股本，留存未分配利润结转至下一年度。 公司 2024 年度利润分配方案已经公司第二届董事会第十三次会议和 第二届监事会第九次会议审议通过，尚需提交公司股东大会审议。 鉴于公司 2024 年度实现归属于上市公司股东的净利润为负，因此不触及 《股票上市规则》第 12.9.1 条第一款第（八）项规定的可能被实施其他风险警 示的情形。 二、本年度不进行利润分配的情况说明 根据中国证监会《上市公司监管指引第 3 号——上市公司现金分红》《成都 思科瑞微电子股份有限公司章程》（以下简称"公司章程"）等 ...

关于前期会计差错更正及 本次会计差错更正影响《2022 年半年度报告》《2022 年第三季度报告》《2022 年年度报告》《2023 年第一季度报告》《2023 年半年度报告》《2023 年第三季度报告》 《2023 年年度报告》《2024 年第一季度报告》《2024 年半年度报告》《2024 年第三 季度报告》的资产负债表、 利润表相关科目。 证券代码：688053 证券简称：思科瑞 公告编号：2025-014 定期报告更正的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 成都思科瑞微电子股份有限公司 公司于2025 年 4 月25日召开第二届董事会第十三次会议和第二届监事会第九次 会议，审议通过了《关于前期会计差错更正及定期报告更正的议案》。按照《企业会 本次会计差错更正，会导致公司《2024 年第三季度报告》年初至报告期末的归 属于母公司所有者的净利润由已披露的-661,377.31 元调整为 1,715,067.11 元，发生 盈亏性质的改变。除此之外，不会导致其他各期定期报告出现盈亏性质的改 ...